nach oben

The journal of nutrition, health & aging

Erschienen in:

27.08.2016

No associations of 25-hydroxycholecalciferol and parathyroid hormone concentrations with calcaneal bone characteristics in community-dwelling elderly subjects: A cross-sectional study

verfasst von: A. Jungert, Monika Neuhäuser-Berthold

Erschienen in: The journal of nutrition, health & aging | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study examined the associations of 25-hydroxycholecalciferol [25(OH)D₃] and intact parathyroid hormone (iPTH) concentrations with bone status parameters in elderly subjects.

Design/Setting

Cross-sectional data based on the follow-up 2008 of the longitudinal study on nutrition and health status of senior citizens in Giessen, Germany.

Participants

One hundred eighty-eight independently living subjects aged 66–96 years.

Measurements

Serum concentrations of 25(OH)D₃, iPTH, N-terminal propeptide of type 1 collagen (P1NP) and activity of alkaline phosphatase (ALP) were assessed. Broadband ultrasound attenuation, speed of sound and stiffness index were determined by calcaneal quantitative ultrasound (QUS). Multiple linear regression analyses were performed to analyse associations of 25(OH)D₃ and iPTH with bone status parameters.

Results

Median (range) 25(OH)D₃ and iPTH concentrations were 62.8 (29.9–106.7) nmol/L and 4.6 (1.3–21.0) pmol/L, respectively. Neither 25(OH)D₃ nor iPTH was associated with calcaneal bone characteristics measured by QUS, whereas negative associations between 25(OH)D₃ and bone formation markers (P1NP and ALP) were found. In a sub analysis, 25(OH)D₃ was negatively associated with ALP only in subjects with iPTH concentrations > 4.59 pmol/L.

Conclusion

The present study provides no evidence for independent associations of 25(OH)D₃ and iPTH with calcaneal bone characteristics in community-dwelling elderly subjects with 25(OH)D₃ concentrations between 30 and 107 nmol/L. However, 25(OH)D₃ interacts with bone formation markers, particularly in subjects with high iPTH concentrations.

Arabi A, Baddoura R, Awada H, Salamoun M, Ayoub G, El-Hajj Fuleihan G. Hypovitaminosis D osteopathy: is it mediated through PTH, lean mass, or is it a direct effect? Bone 2006;39: 268–75.

Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G. PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int 2012;23:971–80.CrossRefPubMed

Bhattoa HP, Nagy E, More C, Kappelmayer J, Balogh A, Kalina E, Antal-Szalmas P. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study. Osteoporos Int 2013;24: 179–86.CrossRefPubMed

Garnero P, Munoz F, Sornay-Rendu E, Delmas PD. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone 2007;40: 716–22.CrossRefPubMed

Ilich JZ, Brownbill RA, Tamborini L. Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density. Eur J Clin Nutr 2003;57: 554–65.CrossRefPubMed

Kauppi M, Impivaara O, Mäki J, Heliövaara M, Marniemi J, Montonen J, Jula A. Vitamin D status and common risk factors for bone fragility as determinants of quantitative ultrasound variables in a nationally representative population sample. Bone 2009;45: 119–24.CrossRefPubMed

Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 2009;94: 1244–50.CrossRefPubMed

Macdonald HM, Mavroeidi A, Barr RJ, Black AJ, Fraser WD, Reid DM. Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone 2008;42: 996–1003.CrossRefPubMed

Olmos JM, Hernández JL, García-Velasco P, Martínez J, Llorca J, González-Macías J. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 2016;27: 105–13.CrossRefPubMed

10.

Saquib N, von Mühlen D, Garland CF, Barrett-Connor E. Serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in men: the Rancho Bernardo study. Osteoporos Int 2006;17: 1734–41.CrossRefPubMed

11.

Sohl E, de Jongh RT, Swart KM, Enneman AW, van Wijngaarden JP, van Dijk SC, Ham AC, van der Zwaluw NL, Brouwer-Brolsma EM, van der Velde N, de Groot CP, te Velde SJ, Lips P, van Schoor NM. The association between vitamin D status and parameters for bone density and quality is modified by body mass index. Calcif Tissue Int 2015;96: 113–22.CrossRefPubMed

12.

van Ballegooijen AJ, Robinson-Cohen C, Katz R, Criqui M, Budoff M, Li D, Siscovick D, Hoofnagle A, Shea SJ, Burke G, de Boer IH, Kestenbaum B. Vitamin D metabolites and bone mineral density: the multi-ethnic study of atherosclerosis. Bone 2015;78: 186–93.CrossRefPubMedPubMedCentral

13.

Vanderschueren D, Pye SR, O’Neill TW, Lee DM, Jans I, Billen J, Gielen E, Laurent M, Claessens F, Adams JE, Ward KA, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Wu FC, Boonen S. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J Clin Endocrinol Metab 2013;98: 995–1005.CrossRefPubMed

14.

Zhen D, Liu L, Guan C, Zhao N, Tang X. High prevalence of vitamin D deficiency among middle-aged and elderly individuals in northwestern China: its relationship to osteoporosis and lifestyle factors. Bone 2015;71: 1–6.CrossRefPubMed

15.

Zochling J, Sitoh YY, Lau TC, Cameron ID, Cumming RG, Lord SR, Schwarz J, Trube A, March LM, Sambrook PN. Quantitative ultrasound of the calcaneus and falls risk in the institutionalized elderly: sex differences and relationship to vitamin D status. Osteoporos Int 2002;13: 882–7.CrossRefPubMed

16.

Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014;4:CD000227.

17.

Rizzoli R, Boonen S, Brandi ML, Bruyère O, Cooper C, Kanis JA, Kaufman JM, Ringe JD, Weryha G, Reginster JY. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 2013;29: 305–13.CrossRefPubMed

18.

Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96: 53–8.CrossRefPubMed

19.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96: 1911–30.CrossRefPubMed

20.

Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359: 1929–36.CrossRefPubMed

21.

Blanchet C, Giguère Y, Prud’homme D, Turcot-Lemay L, Dumont M, Leduc G, Côte S, Laflamme N, Rousseau F, Dodin S. Leisure physical activity is associated with quantitative ultrasound measurements independently of bone mineral density in postmenopausal women. Calcif Tissue Int 2003;73: 339–49.CrossRefPubMed

22.

Martínez J, Olmos JM, Hernández JL, Pinedo G, Llorca J, Obregón E, Valero C, González-Macías J. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta 2009;409: 70–4.CrossRefPubMed

23.

Khosla S. Pathogenesis of age-related bone loss in humans. J Gerontol A Biol Sci Med Sci 2013;68: 1226–35.CrossRefPubMed

24.

Jungert A, Neuhäuser-Berthold M. Sex-specific determinants of serum 25-hydroxyvitamin D3 concentrations in an elderly German cohort: a cross-sectional study. Nutr Metab (Lond) 2015;12:2.CrossRef

25.

Alcaraz A, González-López R, Morote J, de la Piedra C, Meseguer C, Esteban E, Climent M, González-Gragera B, Alvarez-Ossorio JL, Chirivella I, et al. Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study. Br J Cancer 2013;109: 121–30.CrossRefPubMedPubMedCentral

26.

Dusso A, González EA, Martin KJ. Vitamin D in chronic kidney disease. Best Pract Res Clin Endocrinol Metab 2011;25: 647–55.CrossRefPubMed

27.

Vasikaran SD, Chubb SP, Ebeling PR, Jenkins N, Jones GR, Kotowicz MA, Morris HA, Schneider HG, Seibel MJ, Ward G. Harmonised Australian reference intervals for serum PINP and CTX in adults. Clin Biochem Rev 2014;35: 237–42.PubMedPubMedCentral

28.

Woitge HW, Seibel MJ, Ziegler R. Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases. Clin Chem 1996;42: 1796–804.PubMed

29.

Roche Diagnostics GmbH. Elecsys 1010/2010/Modular analytics E170. Parathyroid hormone PTH, intact. Mannheim, Germany: Roche Diagnostics; 2003.

30.

Roche Diagnostics GmbH. Elecsys 1010/2010 and Modular analytics E170, Cortisol. Mannheim, Germany: Roche Diagnostics; 2005.

31.

Roche Diagnostics GmbH. Elecsys and cobas analyzer. 25-Hydroxyvitamin D3, Vitamin D3 (25-OH). Mannheim, Germany: Roche Diagnostics; 2007.

32.

Roche Diagnostics GmbH. Elecsys and cobas e analyzers. Thyrotropin, TSH. Mannheim, Germany: Roche Diagnostics; 2007.

33.

Roche Diagnostics GmbH. Elecsys and cobas e analyzers. Total procollagen type 1 amino-terminal propeptide, total P1NP. Mannheim, Germany: Roche Diagnostics; 2007.

34.

Roche Diagnostics GmbH. Roche/Hitachi. Alkalische Phosphatase flüssig nach IFCC (alkaline phosphatase), ALP. Mannheim, Germany: Roche Diagnostics; 2008.

35.

Roche Diagnostics GmbH. Elecsys 1010/2010/Modular analytics E170. Follikelstimulierendes Hormon (follicle stimulating hormone), FSH. Mannheim, Germany: Roche Diagnostics; 2004.

36.

Roche Diagnostics GmbH. Elecsys 1010/2010/Modular analytics E170. Testosterone. Mannheim, Germany: Roche Diagnostics; 2004.

37.

Roche Diagnostics GmbH. Elecsys 1010/2010 and Modular analytics E170. Estradiol -E2. Mannheim, Germany: Roche Diagnostics; 2005.

38.

Roche Diagnostics GmbH. Elecsys 1010/2010 and Modular analytics E170. Luteinizing hormone, LH. Mannheim, Germany: Roche Diagnostics; 2005.

39.

Levey AS, Greene T, Kusek J, Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000;11:155A.

40.

Edelmann-Schäfer B, Berthold LD, Stracke H, Lührmann PM, Neuhäuser-Berthold M. Identifying elderly women with osteoporosis by spinal dual X-ray absorptiometry, calcaneal quantitative ultrasound and spinal quantitative computed tomography: a comparative study. Ultrasound Med Biol 2011;37: 29–36.CrossRefPubMed

41.

Njeh CF, Blake GM. Calcaneal quantitative ultrasound devices: water coupled. In: Njeh CF, Hans D, Fuerst T, Glüer CC, Genant HK, (eds). Quantitative ultrasound. Assessment of osteoporosis and bone status. London: Martin Dunitz;1999. pp. 109–24.

42.

Roubenoff R, Baumgartner RN, Harris TB, Dallal GE, Hannan MT, Economos CD, Stauber PM, Wilson PW, Kiel DP. Application of bioelectrical impedance analysis to elderly populations. J Gerontol A Biol Sci Med Sci 1997;52:M129–36.CrossRefPubMed

43.

Krems C, Lührmann PM, Neuhäuser-Berthold M. Physical activity in young and elderly subjects. J Sports Med Phys Fitness 2004;44: 71–6.PubMed

44.

Lührmann PM, Herbert BM, Gaster C, Neuhäuser-Berthold M. Validation of a self-administered 3-day estimated dietary record for use in the elderly. Eur J Nutr 1999;38: 235–40.CrossRefPubMed

45.

Michelsen J, Wallaschofski H, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M, Hannemann A. Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone 2013;57: 399–404.CrossRefPubMed

46.

Lee S, Teschemaker AR, Daniel M, Maneno MK, Johnson AA, Wutoh AK, Lee E. Calcium and vitamin D use among older adults in U.S.: results from national survey. J Nutr Health Aging 2016;20: 300–5.CrossRefPubMed

47.

Trimpou P, Bosaeus I, Bengtsson BA, Landin-Wilhelmsen K. High correlation between quantitative ultrasound and DXA during 7 years of follow-up. Eur J Radiol 2010;73: 360–4.CrossRefPubMed

48.

Olmos JM, Hernández JL, Martínez J, Pariente E, Llorca J, González-Macías J. Bone turnover markers in Spanish adult men The Camargo Cohort Study. Clin Chim Acta 2010;411: 1511–5.CrossRefPubMed

Titel: No associations of 25-hydroxycholecalciferol and parathyroid hormone concentrations with calcaneal bone characteristics in community-dwelling elderly subjects: A cross-sectional study
verfasst von: A. Jungert
Monika Neuhäuser-Berthold
Publikationsdatum: 27.08.2016
Verlag: Springer Paris
Erschienen in: The journal of nutrition, health & aging / Ausgabe 6/2017
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI: https://doi.org/10.1007/s12603-016-0785-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

No associations of 25-hydroxycholecalciferol and parathyroid hormone concentrations with calcaneal bone characteristics in community-dwelling elderly subjects: A cross-sectional study

Abstract

Objective

Design/Setting

Participants

Measurements

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Objective

Design/Setting

Participants

Measurements

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Relationship between sensory perception and frailty in a community-dwelling elderly population

Validation of the photography method for nutritional intake assessment in hospitalized elderly subjects

Dietary risk factors by race/ethnicity, age-group, and gender in a representative sample of us older adults

Association of protein intake with bone mineral density and bone mineral content among elderly women: The OSTPRE Fracture Prevention Study

Energy and nutrient content of food served and consumed by nursing home residents

Trajectories of nutritional risk: The Manitoba follow-up study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin